eNeurologicalSci (Dec 2016)

The first report of CADASIL in Peru: Olfactory dysfunction on initial presentation

  • Anastasia Vishnevetsky,
  • Miguel Inca-Martinez,
  • Karina Milla-Neyra,
  • Danny Moises Barrientos-Iman,
  • Ivan Cornejo-Herrera,
  • Carlos Cosentino,
  • Mario Cornejo-Olivas

Journal volume & issue
Vol. 5
pp. 15 – 19

Abstract

Read online

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is a rare, heritable, small vessel vascular disease caused by mutations in the Notch3 gene that is characterized by migraines, subcortical vascular events, cognitive decline, and mood disturbances. However, many CADASIL cases present with unusual symptoms such as status epilepticus, a movement disorder, or sensory dysfunction. This study describes the clinical, genetic, and radiologic characteristics of a Peruvian family with CADASIL in which multiple family members presented with severe olfactory deficits. Seven members of the family have symptoms suggestive of CADASIL, with genetic testing revealing R133C mutations in the two patients who underwent genetic testing. Cognitive testing and olfactory identification testing (Smell Identification Test) were performed in three CADASIL patients revealing total anosmia in two tested patients and severe hyposmia in the other. Olfactory dysfunction has been associated with various neurologic and psychiatric conditions, though few studies have linked it with neurovascular disorders such as CADASIL. This first reported case of CADASIL in Peru emphasizes that symptomatic olfactory dysfunction may be an unusual presentation of CADASIL and that olfactory dysfunction is important to evaluate in CADASIL patients. Keywords: CADASIL, Stroke, Olfactory dysfunction, Olfaction, MRI, NOTCH3, Peru, South America